Table 1.
Family | Age, years | Gender | FAM20A mutations |
---|---|---|---|
1 | 21 | male | c.915–918delCTTT; p.F305fsX380 |
| |||
2 | 27 | female | IVS2 + 1G>A/c.913–914delTT; p.F305fsX378 |
31 | male | IVS2 + 1G>A/c.913–914delTT; p.F305fsX378 | |
| |||
3 | 23 | male | IVS4 + 1G>C/c.1348–1349delTC; p.S450fsX469 |
25 | female | IVS4 + 1G>C/c.1348–1349delTC; p.S450fsX469 | |
| |||
4 | 59 | male | c.1475–1482dupAACCCCAC; p.L495fsX509 |
64 | female | c.1475–1482dupAACCCCAC; p.L495fsX509 | |
| |||
5 | 12 | female | c.406C>T; p.R136X |
| |||
6 | 20 | male | c.34–35delCT; p.L12fsX78 |
| |||
7 | 16 | female | c.1513delA; p.I505fsX506 |
22 | male | c.1513delA; p.I505fsX506 | |
| |||
8 | 20 | male | c.1432C>T; p.R478X |
| |||
9 | 13 | male | c.518T>G; p.L173R |
| |||
10 | 29 | female | c.727C>T/c.1228–1229delGA; p.R243X/p.D410fsX414 |
| |||
11 | 19 | female | c.217C>T/c.727C>T; p.R73X/p.R243X |
20 | male | c.217C>T/c.727C>T; p.R73X/p.R243X | |
| |||
12 | 18 | female | c.1369A>T; p.K457X |
| |||
13 | 14 | female | c.755–757delTCT/c.641–719del79bp; p.F252del/p.I214fsX259 |
16 | male | c.755–757delTCT/c.641–719del79bp; p.F252del/p.I214fsX259 | |
| |||
14 | 21 | female | IVS5 + 2T>G |
| |||
15 | 24 | male | c.907–908delAG; p.S303fsX378 |
31 | male | c.907–908delAG; p.S303fsX378 | |
37 | female | c.907–908delAG; p.S303fsX378 | |
| |||
16 | 17 | female | c.34–35delCT/c.612delC; p.L12fsX78/p.A204fsX215 |
18 | female | c.34–35delCT/c.612delC; p.L12fsX78/p.A204fsX215 |
Mutations are described on the cDNA and predicted protein levels. Listing of one allele indicates homozygosity; two alleles indicate compound heterozygosity. Every patient had biallelic mutations involving insertions, deletions, essential splice sites, missense changes or nonsense changes.